University Hospital Uppsala
Orlistat promotes weight loss and improves glycemic control
Published in Aging and Elder Health Week, June 19th, 2005
In a recent report, researchers in Sweden conducted a study "to assess the effects of orlistat vs placebo, in combination with a weight management program, on weight loss and metabolic control in obese patients with type 2 diabetes. Patients treated with either metformin alone or metformin in combination with sulfonylurea" were randomly assigned" to double-blind treatment with orlistat or placebo (120 mg) three times daily, combined with a mildly reduced calorie diet and a weight management program for 52 weeks. Changes in body weight, anthropometry, glycemic control, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
More Articles from Aging and Elder Health Week
- Access Pharmaceuticals, Inc.
Third oral drug delivery research deal announced - Boehringer Ingelheim GmbHBoehr
ATHOS study results presented at geriatric conference - Bone Care International, Inc.
Medicare Part D coverage includes D-hormone therapy for kidney disease - Collaborations
Cigna HealthCare, NationsHealth team to offer Medicare Part D plans - Collaborations
Humana teams with Argus for pharmacy claims processing - Cytos Biotechnology
Immunodrug candidate CAD106 for Alzheimer disease gets Swedish clearance - More from this issue of Aging and Elder Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
